Unibest
← Back to patent-cliff list

CAS 3395-91-3

3-Bromopropionic acid methyl estermethyl 3-bromopropanoate

Codes: (III)169995-23-a, IBAN-014

Application context (from source-drug indications)

ContraceptionDrospirenoneStomatitis, aphthousDrospirenonePremenstrual dysphoric disorderDrospirenonePremenstrual syndromeDrospirenoneDysmenorrhoeaDrospirenoneDepressionDrospirenoneOsteoporosisIbandronate Sodium Hydrate/ColecalciferolOsteoporosisIbandronate Sodium HydratePostmenopausal osteoporosisIbandronate Sodium HydrateHypercalcaemiaIbandronate Sodium HydrateBone injuryIbandronate Sodium HydrateBreast cancerIbandronate Sodium HydrateMetastatic cancerIbandronate Sodium Hydrate

Source drugs (routes using this intermediate)

DrugTierExpiry
DrospirenoneTier C — Watch / trade-
Ibandronate Sodium Hydrate/ColecalciferolTier C — Watch / trade-
Ibandronate Sodium HydrateTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.